Inflammasome Therapeutics Announces First Patient Dosed in P

Inflammasome Therapeutics Announces First Patient Dosed in Phase I Diabetic Macular Edema Study of the Dual Inflammasome Inhibitor K8

Inflammasome Therapeutics Announces First Patient Dosed in Phase I Diabetic Macular Edema Study of the Dual Inflammasome Inhibitor K8

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Lou Gehrig , Jayakrishna Ambati , Paul Ashton , Beverly Jedynak , University Of Kentucky , Clinical Trial , Intravitreal Injection , Nucleoside Reverse Transcriptase Inhibitor , Diabetic Macular , Michelle Abou Jaoude , Geographic Atrophy , Dry Age Related Macular , Inflammasome Therapeutics , Multiple Sclerosis , Bevlyn Consulting ,